¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ 2022³âµµ Á¦25Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2022-07-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ 2022³âµµ Á¦25Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2022-07-08
±³À°ÀÏÀÚ : 2022-07-08
±³À°Àå¼Ò : ¼­¿ï¿Ã¸²ÇÈÆÄÅ©ÅÚ  
±³À°ÁÖÁ¦ : 2022³âµµ Á¦25Â÷ Çмú´ëȸ (2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ
´ã´çÀÚ : ÀÌÇѳª
¿¬¶ôó : 02-401-1570  
À̸ÞÀÏ : kscm.office@gmail.com      
±³À°Á¾·ù : ³»°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú¹Ì»ý¹°ÇÐ
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 14 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 250,000¿ø      
ºñ°í Á¤È¸¿ø 10¸¸¿ø, ÁØȸ¿ø 5¸¸¿ø, Æò»ýȸ¿ø 10¸¸¿ø, ´Üüȸ¿ø 10¸¸¿ø, ºñȸ¿ø 25¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 07:30~08:10 ME1: Basics in Diagnosis of Fungal Infection  À̹̰æ(Áß¾ÓÀÇ´ë) 
È޽Ġ07-08 ¿Ã¸²ÇǾÆȦ 08:10~09:00 Break/exhibition  () 
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 09:00~09:30 The Response to SARS-CoV-2 variants in Korea-Current perspectives  ±èÀºÁø(Áúº´°ü¸®Ã») 
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 09:30~10:00 Response to the national policy on COVID-19 in a Laboratory  ±è³²Èñ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 10:00~10:30 Debate on Hot Topics: Omicron, To be or Not to be Airborne? Chair: Hee  ÀÌÇõ¹Î(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 10:30~11:00 Debate on Hot Topics: Omicron, To be or Not to be Airborne? Chair: Hee  Ã¤Æò±Õ(¼­¿ïÀÇ´ë) 
È޽Ġ07-08 ¿Ã¸²ÇǾÆȦ 11:00~11:10 Break/exhibition  () 
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 11:10~12:00 Immune response to SARS-CoV-2  Á¶³²Çõ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 12:00~13:00 Microbiology innovation with laboratory automation  Ana María Cárdenas(Sr Director Global Medical Affairs Becton Dickinson and Company) 
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 13:00~13:30 Dilemma: Report of inconclusive SARS-CoV-2 PCR  ¼ºÈï¼·(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 13:30~14:00 Laboratory test for assumption of SARS-CoV-2 infectivity  ±èÀ¯°æ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 14:00~14:30 Potential tests for monitoring clinical course of COVID-19  ¹ÚÁöÈ£(°Ç±¹ÀÇ´ë) 
È޽Ġ07-08 ¿Ã¸²ÇǾÆȦ 14:30~14:50 Break/exhibition  () 
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 14:50~15:20 Current diagnosis of Clostridioides difficile in Korea  Á¤Çý¼±(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 15:20~15:50 Further advances in syndromic tests for sexually-transmitted infection  À¯Àοµ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 15:50~16:20 Recent update on laboratory diagnosis of viral hepatitis  Á¶ÁøÈñ(ÀÌ¿øÀÇ·áÀç´Ü) 
±âŸ 07-08 ¿Ã¸²ÇǾÆȦ 16:20~17:00 Closing Ceremony / General Assembly  () 
±³À°½Ã°£ 07-08 ¼­¿ïȦ 07:30~08:10 ME2 : Laboratory Test for Diagnosis and Management of Tuberculosis  ±èâ±â(¼­¿ïÀÇ°úÇבּ¸¼Ò) 
È޽Ġ07-08 ¼­¿ïȦ 08:10~09:00 Break/exhibition  () 
±³À°½Ã°£ 07-08 ¼­¿ïȦ 09:00~10:00 Oral Presentation I  È«¼º±Ù ½ÅÈñºÀ(Â÷ÀÇ´ë ¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 07-08 ¼­¿ïȦ 10:00~11:00 Oral Presentation II  ±èÇö¼ö ½Å¼ö(ÇѸ²ÀÇ´ë ¼­¿ïÀÇ´ë) 
È޽Ġ07-08 ¼­¿ïȦ 11:00~11:10 Break/exhibition  () 
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 11:10~12:00 Immune response to SARS-CoV-2  Á¶³²Çõ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 07-08 ¼­¿ïȦ 12:00~13:00 Comparative diagnostic accuracy of POC assay for the molecular diagnosis of SARS-CoV-2 in the Point-of-Care and critical care settings  Alexander Domnich(SanMartino Hospital Italy) 
È޽Ġ07-08 ¼­¿ïȦ 13:00~13:30 Current status and future perspectives of Kor-GLASS  ½ÅÁ¾Èñ(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 07-08 ¼­¿ïȦ 13:30~14:00 Changes in major AMR trends amidst the COVID-19 pandemic  Á¤¼®ÈÆ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 07-08 ¼­¿ïȦ 14:00~14:30 Emerging AMR identified through the Kor-GLASS  ±èµµ±Õ(¿¬¼¼ÀÇ´ë) 
È޽Ġ07-08 ¼­¿ïȦ 14:30~14:50 Break/exhibition  () 
±³À°½Ã°£ 07-08 ¼­¿ïȦ 14:50~15:20 New technique of disinfection  ÀÌÁö¿µ(¼­¿ï¼º¸ðº´¿ø) 
±³À°½Ã°£ 07-08 ¼­¿ïȦ 15:20~15:50 Strategy of CPE infection control  À̽¿Á(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 07-08 ¼­¿ïȦ 15:50~16:20 Diagnosis and management of catheter-associated infection  ¹ÚÁ¤¼ö(¼­¿ïÀÇ´ë) 
±âŸ 07-08 ¿Ã¸²ÇǾÆȦ 16:20~17:00 Closing Ceremony / General Assembly  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ 2022³âµµ Á¦25Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2022-07-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022 Àü³²´ëÇб³º´¿ø Á¤½Å°Ç°­ÀÇÇаú ±¹Á¦ ½ÉÆ÷Áö¾ö(Äڷγª19 °¨¿° Àå±âÈ­¿Í Á¤½Å°Ç°­) : 2022-07-08
´ÙÀ½±Û ´ëÇÑÅ»ÀåÇÐȸ The 16th Congress of the KHS & 1st International Symposium 2022 : 2022-07-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20620 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼­¿ï¾Æ»êº´¿ø ´ç´¢º´ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-30 0 98 2024-04-30
20619 °æ³² »ï¼ºÃ¢¿øº´¿ø (¿Â¶óÀÎ)»ï¼ºÃ¢¿ø Ambulatory Pediatrics 2024 : 2024-06-29 0 80 2024-04-30
20618 °æºÏ Á¦8Â÷ ´ëÇѸðüžÆÀÇÇÐȸ °³¿øÀǸ¦ À§ÇÑ ¿¬¼ö°­ÁÂ(¿µ³²) : 2024-06-29 0 35 2024-04-30
20617 ¼­¿ï °Ç±¹´ëÇб³º´¿ø 2024 KUMC Precision Medicine Lung Cancer Conference : 2024-06-28 0 25 2024-04-30
20616 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ ÀûÇ÷±¸Áúȯ¿¬±¸ ½ÉÆ÷Áö¾ö : 2024-06-28 0 42 2024-04-30
20615 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ ÀÇ·ÚÇÑ µÎ°æºÎ¾Ï ȯÀÚÀÇ Ä¡·á ¹× °æ°ú : 2024-06-27 0 32 2024-04-30
20614 ¼­¿ï 2024³â ´ëÇÑÈäºÎ¿µ»óÀÇÇÐȸ ¿¬¼ö°­Á : 2024-06-23 0 26 2024-04-30
20613 ´ë±¸ ´ëÇѽºÆ÷Ã÷ÀÇÇÐȸ Sports Medicine Symposium 2024 in Daegu : 2024-06-23 0 63 2024-04-29
20612 ¼­¿ï 2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦12Â÷ Clinical Densitometry Course : 2024-06-23 0 45 2024-04-29
20611 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 1Â÷(2ÀÏÂ÷) : 2024-06-22 0 51 2024-04-29
20610 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø (¿Â¶óÀÎ) 6¿ù 21ÀÏ ±Ý¿äÁý´ãȸ(ÀÌ°ü ÁúȯÀÇ Áø´Ü°ú Ä¡·á) : 2024-06-21 0 45 2024-04-29
20609 °æ±â ¾È»ê ¹× ½ÃÈ­Áö¿ª À̺ñÀÎÈÄ°ú Àǻ縦 À§ÇÑ Áý´ãȸ(¾È¸é¸¶ºñ) : 2024-06-21 0 35 2024-04-29
20608 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 1Â÷(1ÀÏÂ÷) : 2024-06-21 0 43 2024-04-29
20607 ¼­¿ï 2024 ´ëÇÑȯ°æõ½ÄÆóÁúȯÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-21 0 46 2024-04-29
20606 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-¿Ü·¡¿¡¼­ °£´ÜÇÏ°Ô ÇÒ ¼ö ÀÖ´Â À½¼ºÄ¡·á : 2024-06-20 0 30 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷